Ardelyx Inc. said March 14 that it appointed Jan Lundberg to its board, effective March 23.
Lundberg is executive vice president of science and technology and president of Lilly Research Laboratories at Eli Lilly and Co.
Fremont, Calif.-based Ardelyx develops and sells therapeutics for the treatment of cardiorenal and gastrointestinal diseases in the U.S.
